Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ibex, Ortho Regenerative Technologies.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axonics, Implandata, Neuropace.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Aerie, AI Therapeutics, Amarin, Dalcor, Dare, Destiny, Eyepoint, Immunic, Jcyte, Moderna, NGM, Opthea, Promab, Puma, Rezolute, Rigel, TCR2.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: enscript, Polarityte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alector, Amgen, Chi-Med, Cytomx, Northwest, Noxxon, Polarityte, Theratechnologies, UCB.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Philips.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acurx, Ampio, Aravive, Clarity, Corcept, Genfit, Incyte, Pipeline, Quadriga.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Roche, Seer, Singlera Genomics, Spineway.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Azurrx, Axogen, Belite, Genentech, Horizon, Regulus, Scynexis, Springworks, Talaris, Terns, TG, Transgene, Valneva.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akebia, Algernon, Ascletis, Astrazeneca, Bioarctic, Biogen, Biontech, Calcimedica, Celltrion, China National, Dynavax, Eisai, Glaxosmithkline, Heron, Medicago, Moderna, Neurorx, Pfizer, Phasebio, Relief, Ribomic, Rigel, Santen, Synairgen.